Abstract
Five alkaloid compounds (1–5), including one new compound, GKK1032C (1), and four known compounds, pyrrospirones E (2) and F (3), and GKK1032B (4) and A2 (5) were isolated from the culture of endophytic fungus Penicillium sp. CPCC 400817. The planar structures of all compounds were elucidated by NMR and MS spectra. The relative configuration of new compound GKK1032C (1) was deduced from the vicinal J-values and ROESY spectral data. Compound 1 exhibited potent antibacterial activity against methicillin-resistant Staphylococcus aureus with an MIC value of 1.6 μg ml−1.
Microorganisms produce a remarkable array of small bioactive molecules that represent most of our new drugs, especially antibiotics [1]. The emergence and spread of antibacterial resistance are jeopardizing the effectiveness of most antibiotics in clinical use and are threatening to the public health worldwide; therefore it is imperative to develop new antibiotics to combat resistant pathogens [2]. In our ongoing screening program to discover new compounds against drug-resistant pathogens from microbes [3,4,5,6], it was found that the culture of strain CPCC 400817 exhibited good antibacterial activity. CPCC 400817, an endophytic Penicillium sp. strain, was isolated from a mangrove plant collected in Dongzhai harbor of Hainan province, which is deposited at the China Pharmaceutical Culture Collection (No. CPCC 400817). Investigation of the bioactive metabolites of CPCC 400817 led to the discovery of five alkaloid compounds, including one new compound, GKK1032C (1), and four known compounds (Fig. 1), pyrrospirones E (2) and F (3) [7], as well as GKK1032B (4) [8] and A2 (5) [9] (see the Supporting Information). Here we report their isolation, purification, structural elucidation and bioassay.
The strain was cultured on a PDA slant containing 0.3% potato extract, 2% glucose, and 1.5% agar at 25 °C for 5 days, then inoculated in 500-ml Erlenmeyer flasks containing 100 ml of F1 medium (2.0% glucose, 1.0% glycerol, 0.2% soybean powder, 1.0% sucrose, 1.0% peptone, 0.25% PEG (6000), 0.03%K2HPO4, 0.3% (NH4)2SO4, 0.3% NaNO3, pH 6). The flasks were placed in dark at 25 °C for 30 days without shaking. The culture (10 l) was filtered to separate the mycelia from the supernatant. The mycelia were extracted with acetone (3 × 10 l), and after recovering the organic solvent, the crude material was further extracted with EtOAc (3 × 3 l). The EtOAc-soluble fraction (8.7 g) was subjected to ODS column chromatography (MeOH/H2O, v/v, 3:7 → 7:3 → 10:0) to finally yield six combined fractions (Fr. A to F). By repeated purification using semipreparative HPLC on a ReproSil-Pur Basic C18 column (5 μm, 250 × 10 mm) with an isocratic elution (MeOH-H2O) at a flow rate of 2.5 ml min−1, compounds 1 (4.3 mg), 2 (5.3 mg), 3 (5.6 mg), and 5 (10 mg) were obtained from Fr. D, and compound 4 (6 mg) was obtained from Fr. C.
GKK1032C (1) was obtained as white powder and was determined to have a molecular formula of C32H39O5N, based on high resolution electrospray ionization mass spectrometry (HR-ESIMS) [M - H]− m/z 516.2756 and analysis of 1H and 13C NMR data. The planar structure of 1 was deduced by interpretation of 1H and 13C NMR, 1H-1H COSY, HSQC and HMBC spectral data (Table 1) and comparison of these data with those of related alkaloids [9, 10]. Detailed analysis of 1H-1H COSY spectrum disclosed the presence of the spin systems CH2 = CH-, -CH2CH(CH3)CH2CH(CH3)CHCHCH(CH)CH-, and that due to a para-substituted benzene ring with restricted free rotation. Further comprehensive analysis of NMR data indicated that 1 contained a γ-lactam moiety (δc-18 168.44) and a decahydrofluorene ring system bearing five methyl groups at C-3, C-5, C-7, C-9, C-11 and an CH2 = CH- group at C-3 (Fig. 2). The γ-lactam system was deduced from the chemical shift data and HMBC correlations from NH to C-2′, C-1′, C-17 and C-18, and from H-1′ to C-2′, C-17 and C-18. The decahydrofluorene ring system was connected at C-15 to the α-carbon (C-17) of the γ-lactam moiety via a ketone (δc-16 203.02), as indicated by the HMBC correlations H-15/C-16, NH/C-18, NH/C-17, NH/C-16. Additionally, the HMBC correlations from H-3′ to C-1′, C-2′, C4′, C-5a′ and C-5b′ suggested that the para-substituted benzene ring is attached to γ-lactam system via a methylene group. The presence of the HMBC correlation from H-13 (δ 4.70) to the oxygenated aromatic carbon (C-7′, δ157.72) indicated that the para-substituted benzene ring is attached to the decahyrofluorene ring system at C-13 through an oxygen atom. The chemical shifts of the adjacent carbons C-1′ (66.85) and C-17 (58.59) suggested that they were oxygenated and might form an oxirane ring, which is further confirmed by the molecular formula and the unsaturation degrees of the molecule. Thus, the planar structure of 1 was determined.
The relative configuration of 1 was elucidated by analysis of vicinal J-values and ROESY spectral data (Fig. 3). The large vicinal coupling constants of J8a, 9 = 11.9 Hz, J10a, 11 = J10a, 9 = 12.4 Hz, J11, 12 = 10.5 Hz and J14, 6 = 12.9 Hz demonstrated that these protons are axial. The ROESY correlations of H-8a/H-10a, H-10a/H-12, H-12/H-6, H-6/H-13, H-13/H-15, and H-6/3-Me indicated that they were cofacial. The same orientation of H-14, 7-Me, H-9, H-11, and CH2 = CH- was suggested by ROE correlations of H-14 with H-2, 7-Me with H-9, H-11, and H-14. On the basis of the above ROEs and coupling constants, the relative stereochemistry of the decahyrofluorene ring system could be established as the trans-juncture for A/B and B/C rings. In addition, H-13 only showed correlations with aromatic H-6′a, but not with H-6′b, confirming that para-substituted benzene ring is rotation-restricted and approximately vertical to the rigid decahyrofluorene ring. Furthermore, H-1′ correlated only to H-5′b and H-6′b, whereas NH correlated only to H-5′a, suggesting that the γ-lactam ring is nearly parallel to the benzene ring and affording the relative configuration of the γ-lactam ring. Thus, compound 1 was deduced to share a similar structural framework with GKK1032A2 (5), and named as GKK1032C.
GKK1032C (1) together with compounds 2–4 were assayed for their antibacterial activity by using micro broth dilution method. Vancomycin (against Gram-positive bacteria) and Meropenem (against both Gram-positive and Gram-negative bacteria) were selected for the references. The results (Table 2) disclosed that all tested compounds exhibited potent antibacterial activity against Gram-positive bacteria, including methicillin-susceptible and methicillin-resistant Staphylococcus aureus (MIC: 1.6–25.8 μg ml−1), but no activity against Gram-negative bacteria, Escherichia coli, Pseudomonas aeruginosa and Acinetobacter baumannii (MIC > 25.8 μg ml−1). (Table 2) Among these five compounds, new compound GKK1032C (1) afforded the most potent activity against methicillin-susceptible and methicillin-resistant Staphylococcus aureus with MIC values of 3.2 and 1.6 μg ml−1, respectively, which were comparable with those of vancomycin.
References
Newman DJ, Cragg GM. Natural products as sources of new drugs from 1981 to 2014. J Nat Prod. 2016;79:629–61.
World Health Organization. Prioritization of pathogens to guide discovery, research and development of new antibiotics for drug resistant bacterial infections, including tuberculosis. World Health Organization; 2017.
Xie Y, et al. NRPS substrate promiscuity leads to more potent antitubercular sansanmycin analogues. J Nat Prod. 2014;77:1744–8.
Xie Y, Xu H, Sun C, Yu Y, Chen R. Two novel nucleosidyl-peptide antibiotics: Sansanmycin F and G produced by Streptomyces sp SS. J Antibiot (Tokyo). 2010;63:143–6.
Xie Y, Xu H, Si S, Sun C, Chen R. Sansanmycins B and C, new components of sansanmycins. J Antibiot (Tokyo). 2008;61:237–40.
Xie Y, Chen R, Si S, Sun C, Xu H. A new nucleosidyl-peptide antibiotic, sansanmycin. J Antibiot (Tokyo). 2007;60:158–61.
Song T, Chen M, Chai W, Zhang Z, Lian XY. New bioactive pyrrospirones C-I from a marine-derived fungus Penicillium sp. ZZ380. Tetrahedron. 2018;74:884–981.
Qader M, Kumar NS, Jayasinghe L, Fujimoto Y. Production of antitumor antibiotic GKK1032B by Penicillium citrinum, an endophytic fungus isolated from Garcinia mangostana Fruits. Med Aromat Plants. 2015;5:225.
Becker J, Liermann JC, Opatz T, Anke H, Thines E. GKK1032A(2), a secondary metabolite from Penicillium sp. IBWF-029-96, inhibits conidial germination in the rice blast fungus Magnaporthe oryzae. J Antibiot (Tokyo). 2012;65:99–102.
He H, Yang H, Biglelis R, Solum EH, Greenstein M, Carter GT. Pyrrocidines A and B, new antibiotics produced by a filamentous fungus. Tetrahedron Letters. 2002;43:1633–6.
Acknowledgements
We acknowledge financial support from the National Mega-Project for Innovative Drugs (2018ZX09711001-007-001), the National Infrastructure of Microbial Resources (No. NIMR-2018-3), Natural Science Foundation of Beijing Municipality (7172137), and CAMS Innovation Fund for Medical Sciences (CIFMS, No. 2016-I2M-2-002).
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Additional information
Publisher’s note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
41429_2019_144_MOESM1_ESM.docx
GKK1032C, a new alkaloid compound from endophytic fungus Penicillium sp. CPCC 400817 with activity against methicillin-resistant S. aureus
Rights and permissions
About this article
Cite this article
Qi, X., Li, X., Zhao, J. et al. GKK1032C, a new alkaloid compound from the endophytic fungus Penicillium sp. CPCC 400817 with activity against methicillin-resistant S. aureus. J Antibiot 72, 237–240 (2019). https://doi.org/10.1038/s41429-019-0144-5
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41429-019-0144-5
This article is cited by
-
Investigation of Antimicrobial Activities and Molecular Docking Studies of Synthesized Sulfonamide Compounds
Pharmaceutical Chemistry Journal (2023)
-
Biological potential of bioactive metabolites derived from fungal endophytes associated with medicinal plants
Mycological Progress (2021)
-
Endophytic Penicillium species and their agricultural, biotechnological, and pharmaceutical applications
3 Biotech (2020)